Skip to main content
. 2020 Sep 16;10:15154. doi: 10.1038/s41598-020-72082-8

Figure 2.

Figure 2

Changes in the expression of biologic markers in the esophageal mucosa after eight weeks of proton pump inhibitor administration. Nine inflammatory markers (IFN-γ, IL-1β, IL-6, IL-8, IL-10, MCP1, NF-κB, RANTES, and TNF-α), four permeability markers (OCLN, ZO-1, CLDN-1, and CLDN-4), and two hypersensitivity markers (ASIC-3 and TRPV1) were assessed. The expression levels of IL-6, IL-8, NF-κB, TNF-α, CLDN-1, and TRPV1 showed statistically significant decrease after PPI administration. All nine inflammatory markers, except IL-1β, showed a tendency for decreased expression after PPI administration. Lines indicate the medians with interquartile ranges. P-values were indicated only if the comparisons were significant. PPI, proton pump inhibitor.